Antimicrobial resistance (AMR) is a major global health threat. Aidian takes part in supporting antimicrobial stewardship and sustainable us...

1. června 2022
Novinky, AMR

The new In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) entered into application on 26 May 2022. The new regulation will...

31. května 2022
Novinky, Novinky o produktech

We are happy to announce that the Norwegian family-owned investment company Ferd will come as a co-owner of Aidian together with Nordstjerna...

2. května 2022
Novinky

Viruses are major causes of upper respiratory tract infections (URTIs). Yet, antibiotics are commonly prescribed for URTIs. Even if, the flu...

28. dubna 2022
Novinky, Novinky o produktech

We have updated our website with a new sustainability section. You can now find more information about sustainability at Aidian, our commitm...

26. dubna 2022
Novinky

LabPad and LabPad Evolution systems from Biosynex are now available through Aidian offices in the Czech Republic, Slovakia and Hungary. Lab...

12. dubna 2022
Novinky, Novinky o produktech

Emerging evidence show that among patients with COVID-19, the risk of death of diabetes is 50% higher than those without diabetes, especiall...

29. března 2022
Novinky, Novinky o produktech, COVID-19

Aidian is a proud distributor of the Meridian's flexible fully automated molecular PCR platform Revogene® that is capable of both single ana...

24. března 2022
Novinky, Novinky o produktech